Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bacteria infections
Pharma
Breaking down Iterum's UTI antibiotic launch in the US
Iterum has officially launched Orlynvah, which won FDA approval last fall to treat uncomplicated UTIs in women with limited oral treatment options.
Fraiser Kansteiner
Aug 20, 2025 8:01am
Zai Lab taps Pfizer to help market antibacterial drug Xacduro
Nov 22, 2024 9:36am
Iterum nabs FDA approval for oral UTI drug after prior rejection
Oct 25, 2024 2:52pm
FDA approves Utility’s Pivya to treat urinary tract infections
Apr 25, 2024 6:12am
Arch Biopartners bags rights to bactericidal drug in wound care
Mar 30, 2021 8:20am
Scientists create one-dose, temperature-stable ear infection gel
Oct 6, 2020 2:00pm
